Pharmaceutical services company Thryocare Technologies reported strong results for Q3 this financial year, showing 25.4% growth in income compared to the same quarter last year. The total Q3 income of Rs. 71 crore for the quarter came with Rs. 15.3 crore net profit, a 42% profit growth for the quarter. The company has been operating with a low-cost, online driven and franchise model that has proved popular in large cities for diagnostic tests.
The company has seen strong results for the past two quarters of FY17, and announced an interim dividend of Rs. 5 per share.